Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
批准号:
9242168
负责人:
BARBARA L. KEE
金额:
$39.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-19 至 2021-11-30
关键词:
Alpha CellAntigensApplications GrantsAsthmaAtherosclerosisAutoimmune DiseasesAutoimmunityBCL6 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell CountCell Differentiation processCell LineageCell physiologyCellsCytotoxic T-LymphocytesDataDendritic CellsDevelopmentDiseaseE proteinEctopic ExpressionEffector CellEnsureFailureGATA3 geneGene ExpressionGene Expression ProfileGene TargetingGenetic TranscriptionGlycolipidsGrantHypersensitivityID2 geneIL17 geneIL4 geneIgEImmuneImmune responseImmune systemInsulin-Dependent Diabetes MellitusInterceptInterferon Type IIInterleukin-7InvadedMalignant NeoplasmsMemoryMolecularMultiple SclerosisMusNatural ImmunityPhenotypePlayPopulationPredispositionProductionProteinsRegulationRepressionResearchRheumatoid ArthritisRoleSerumSpecific qualifier valueSystemSystemic Lupus ErythematosusT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTCF3 geneTestingTherapeuticTherapeutic AgentsThymus GlandTuberculosisWNT Signaling PathwayZNF145 geneadaptive immunityantimicrobialbasec-myc Proto-Oncogenescell typecytokineexperimental studygraft vs host diseasehelix-loop-helix protein differentiation inhibitorin vivoin vivo Modelinhibitor/antagonistinsightmutantnovelpathogenprotein Ethymocytetranscription factor
中文摘要
项目概要
不变自然杀伤 T (iNKT) 细胞是位于边界的 T 淋巴细胞的一个子集
适应性和先天免疫。它们具有高度受限的 T 细胞受体 (TCR)
检测由非经典 MHC 分子 CD1d 呈递的糖脂抗原,它们
对抗原或细胞因子刺激做出快速反应。 NKT细胞在以下方面发挥着重要作用
抗微生物免疫反应,并且由于它们快速产生多种
细胞因子它们被认为是癌症和其他疾病的治疗剂。
NKT 细胞因其独特的机制而获得效应表型
胸腺中的选择和分化。 NKT 细胞的效应命运范围
NKT细胞的控制机制才刚刚开始被人们所认识
效应器命运选择完全未知。我们的研究旨在了解
控制 iNKT 细胞发育的分子机制,重点关注 E
蛋白质转录因子、其抑制剂、ID 蛋白质及其下游靶标。
这些蛋白质是 iNKT 细胞数量和效应细胞命运选择的关键调节因子。
在此拨款申请中,我们提出实验来确定 E2A 的要求
在 iNKT 细胞发育中,两种过度表达和表达不足的后果
推定的 E2A 靶基因 Lef1 和 Bcl6。我们的研究将对我们产生重大影响
了解 NKT 细胞数量和功能如何调节。此外,我们的研究
将深入了解操纵 NKT 细胞效应器命运的机制,从而
从一开始就改变免疫反应。
英文摘要
Project Summary
Invariant natural killer T (iNKT) cells are a subset of T lymphocytes that sit at the boarder
of adaptive and innate immunity. They have highly restricted T cell receptors (TCRs) that
detect glycolipid antigen presented by the non-classical MHC molecule CD1d and they
respond rapidly to antigen or cytokine stimulation. NKT cells play an important role in
anti-microbial immune responses and because of their rapid production of multiple
cytokines they are being considered as therapeutic agents in cancer and other diseases.
NKT cells acquire their effector phenotype as a consequence of their unique mechanism
of selection and differentiation in the thymus. The range of effector fates that NKT cells
can acquire is only beginning to be appreciated but the mechanisms controlling NKT cell
effector fate choice are completely unknown. Our research is directed at understanding
the molecular mechanisms that control iNKT cell development with a focus on the E
protein transcription factors, their inhibitors the ID proteins, and their downstream targets.
These proteins are critical regulators of iNKT cell numbers and effector cell fate choice.
In this grant application we propose experiments to determine the requirements for E2A
in iNKT cell development an the consequences of over- and under-expression of two
putative E2A target genes, Lef1 and Bcl6. Our studies will have a major impact on our
understanding of how NKT cell number and function is regulated. In addition, our studies
will provide insight into mechanisms to manipulate NKT cell effector fate and thereby
alter immune responses at their inception.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating Helios as a regulator of natural killer cell effector maturation
-
批准号:10608673
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2023
-
负责人:BARBARA L. KEE
-
依托单位:
Identification of BATF function and targets during NK cell activation
-
批准号:10494220
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2021
-
负责人:BARBARA L. KEE
-
依托单位:
Identification of BATF function and targets during NK cell activation
-
批准号:10354363
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2021
-
负责人:BARBARA L. KEE
-
依托单位:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
-
批准号:10065488
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2016
-
负责人:BARBARA L. KEE
-
依托单位:
Molecular Mechanisms of Invariant Natural Killer T Cell Differentiation
-
批准号:10627307
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2016
-
负责人:BARBARA L. KEE
-
依托单位:
Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis
-
批准号:8959799
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2015
-
负责人:BARBARA L. KEE
-
依托单位:
EZH2 in lymphoid lineage specification and commitment
-
批准号:8622415
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8791299
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10540688
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8638491
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8890271
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10318983
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
EZH2 in lymphoid lineage specification and commitment
-
批准号:8788383
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10084246
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
E and Id protein function in natural killer T cell differentiation
-
批准号:8735243
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2013
-
负责人:BARBARA L. KEE
-
依托单位:
GATA3 deregulation and T cell transformation in E2A-/- mice
-
批准号:8265238
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2011
-
负责人:BARBARA L. KEE
-
依托单位:
GATA3 deregulation and T cell transformation in E2A-/- mice
-
批准号:8189155
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2011
-
负责人:BARBARA L. KEE
-
依托单位:
Mechanisms of Lymphocyte Gene Regulation by E2A and Notch1
-
批准号:7835645
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Hematopoiesis
-
批准号:7742075
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Hematopoiesis
-
批准号:7897688
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: